Recent insider trading activity from O'Meara Maeve, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 26, 2023 | Oncology Institute, Inc. | $TOI | O'Meara Maeve | Director | A | Common stock | 50000 | $0.00 | 109,104.0000 | 73,265,621 | 84.60% | 0.07% |
| March 17, 2023 | Oncology Institute, Inc. | $TOI | O'Meara Maeve | Director | A | Common stock | 16404 | $0.00 | 59,104.0000 | 73,265,621 | 38.42% | 0.02% |